AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...

Market OutlineThe Global Artificial Blood Cells Market is valued at USD 1.355 Billion in 2024 and is projected to attain a value of USD 5.265 Billion by 2035 at a CAGR of 13.15% during the forecast ...

AMAZING INVENTIONS EVERYONE should SEE Subscribe my channel to get know all news! HomeBiogas Israeli company HomeBiogas has ...

Pharmaceutical industry accidents raise concerns about worker and community safety, prompting calls for stricter regulations ...